Related by context. All words. (Click for frequent words.) 73 Li Fraumeni Syndrome 68 FOLOTYN ® 68 refractory chronic lymphocytic 67 Proxinium TM 67 PNP inhibitor 66 Zenvia ™ 66 Soliris TM eculizumab 66 oral ridaforolimus 66 personalized cellular immunotherapy 65 antibody MAb 65 IgG1 monoclonal antibody 65 Personalized Immunotherapy 65 delivers fluocinolone acetonide FA 65 markets HP Acthar 65 Genasense ® 65 Factor VIIa 65 targeted radiotherapeutic 65 Cellegesic 65 recurrent refractory 65 dasatinib Sprycel ® 65 modified glutathione analog 65 CCR9 antagonist 65 pseudobulbar affect PBA 65 Romidepsin 65 MyVax R 65 molecular imaging radiopharmaceutical 65 recurrent glioblastoma multiforme 65 hypereosinophilic syndrome 65 intravesical infusion therapy 65 novel emulsion formulation 65 Vicinium TM 64 ThermoDox R 64 Iluvien ® 64 MAGE A3 ASCI 64 ADVEXIN 64 NASDAQ INGN 64 vinorelbine tartrate 64 Zevalin R Ibritumomab 64 Cx# [002] 64 IL# PE#QQR 64 LymphoStat B TM 64 acetonide FA 64 DPX Survivac 64 Zingo TM 64 OMAPRO ™ 64 oral prodrug 64 Campath alemtuzumab 64 Initiates Enrollment 64 PDX pralatrexate 64 investigational immunotherapy 64 dextromethorphan quinidine 64 sorafenib tablets 64 Pegloticase 64 liver resection surgeries 64 PF # [002] 64 ZFP Therapeutics 64 R sorafenib tablets 64 opioid induced constipation OIC 64 Phase #b/#a clinical 64 relapsed leukemia 64 Advexin 64 Insegia 64 Ceflatonin 64 autologous cellular immunotherapy 64 dermatology biopharmaceutical 64 Initiates Phase II 64 refractory Hodgkin lymphoma 64 PLK1 SNALP 64 Ocrelizumab 64 severe hypercholesterolemia 64 myelodysplastic myeloproliferative diseases 64 Ixempra 64 acyclovir Lauriad R 64 EVIZON TM 64 Manja Bouman CEO 63 novel therapeutic antibodies 63 ZOLINZA 63 Allovectin 7 63 Generx TM 63 VitiGam 63 psoriasis rheumatoid arthritis 63 Granted Orphan Drug 63 AAG geldanamycin analog 63 generation purine nucleoside 63 successfully commercialize Iluvien 63 Initiate Clinical Trial 63 Panzem R 63 Peginterferon alfa 2b 63 Mepact 63 KNS # 63 MyVax ® 63 PNT# 63 Receives Orphan Drug Designation 63 Completes Patient Enrollment 63 HuMax TAC 63 IMA# 63 Annamycin 63 4SC AG ISIN DE# 63 octreotide implant 63 NeoLipid R 63 humanised monoclonal antibody 63 Gendux 63 Panzem R NCD 63 progressive metastatic prostate 63 Troxatyl 63 huC# DM4 63 initiated Phase 1b 63 CEQ# 63 ABI OTCBB AMAR 63 ADVEXIN clinical 63 Myrexis Inc. 63 ELADUR ™ 63 XL# anticancer compounds 63 forodesine 63 GVAX ® 63 systemic anaplastic large 63 Oracea TM 63 Files Investigational 63 Degarelix 63 Aviptadil 63 Novolimus 63 Vandetanib 63 SinuNase TM 63 corticotropin injection 63 Xcytrin R 63 PANVAC VF 63 cutaneous T 63 FDA Approvable Letter 63 ZEVALIN ® 63 pralatrexate injection folate analogue 63 histone deacetylase HDAC inhibitor 63 Application BLA 63 IAP inhibitor 63 PrevOnco 62 class mGluR5 inhibitor 62 Surfaxin LS 62 KRN# 62 Evoltra ® 62 Tectin TM 62 cell lymphoma CTCL 62 refractory acute promyelocytic 62 Somatuline Depot 62 Fx #A 62 PHX# 62 Iluvien TM 62 ZACTIMA 62 cetuximab Erbitux R 62 Aryplase 62 Begins Dosing 62 Spiegelmer ® 62 pancreatic enzyme replacement 62 Cinryze TM 62 Ganite ® 62 Fast Track Status 62 TKM PLK1 62 TKM ApoB 62 Zorbtive TM 62 essential thrombocythemia ET 62 ALVESCO R 62 Dacogen injection 62 targeted antifolate 62 HP Acthar Gel repository 62 ruxolitinib 62 Fibrillex TM 62 OncoVex 62 ALN PCS 62 trastuzumab DM1 T DM1 62 JAK2 Inhibitor 62 IMC #B 62 Romiplostim 62 osteolytic bone disease 62 Pivotal Phase III 62 Soliris eculizumab 62 unique alkylating agent 62 tiapamil 62 Aflibercept 62 Nexavar ® 62 JAK2 inhibitor 62 SinuNase ™ 62 phase IIb clinical 62 radiation sensitizer 62 methylnaltrexone bromide 62 Inc. Nasdaq IDMI 62 TRANSDUR ® 62 non nucleoside inhibitor 62 Kit CD# positive 62 tafamidis 62 hypoxia activated prodrug 62 rALLy clinical trial 62 Prestara 62 sarcoma melanoma 62 metastatic castrate resistant 62 Steven R. Deitcher 62 cinacalcet HCl 62 Nabi HB Intravenous 62 ospemifene 62 CVBT #B 62 sirtuin inhibitor program 62 metastatic colorectal 62 NASDAQ PCYC 62 Nasdaq DVAX 62 Combidex 62 thetreatment 62 kidney urologic 62 PGL# 62 Prochymal TM 62 ALTROPANE R 62 TRANSDUR ™ 62 Fast Track Designation 62 Cloretazine 62 oncolytic virus therapies 62 SNS# T 62 Vitrasert R 62 GLOBE NEWSWIRE Cyclacel Pharmaceuticals 62 alvespimycin 62 BLP# Liposome Vaccine 62 TYZEKA 62 Bendamustine 62 volociximab 62 GRN# 62 CYT# potent vascular disrupting 62 Daclizumab 62 Modrenal R 62 Xcellerated T Cells 62 Glufosfamide 62 Inc. Nasdaq IMGN 62 Rhucin ® recombinant 62 Receives Fast Track 61 Ostarine ™ 61 lead molecular radiotherapeutic 61 SUPPRELIN R LA 61 subcutaneous formulation 61 Hsp# Inhibitor 61 StromaCel Inc. 61 XIAFLEX ™ 61 candidates Azedra TM 61 nasal calcitonin product 61 castrate resistant prostate cancer 61 PEGylated Fab fragment 61 Files IND 61 Omapro 61 Nasdaq HALO 61 FDA APPROVES 61 Meets Primary Endpoint 61 Genasense R 61 subsidiaries visit http:/www.apricusbio.com 61 mertansine 61 Lucanix R 61 cancer neuroendocrine tumor 61 gastrointestinal stromal tumors 61 Seliciclib 61 oral talactoferrin 61 Bicifadine 61 Selective Electrochemical Tumor Ablation 61 CINTREDEKIN BESUDOTOX 61 TELINTRA 61 XYOTAX TM 61 Allovectin 7 ® 61 AMEX RGN 61 Initiates Phase III 61 Pyridorin 61 Icatibant 61 KIACTA ™ 61 MOZOBIL 61 Inc. OTCBB SYBD 61 ELACYT 61 Crofelemer budesonide foam 61 BRIM2 61 OTCBB CVBT 61 Virulizin ® 61 ATL# [001] 61 Sudhir Agrawal D.Phil 61 PLX MS 61 FUSILEV ® 61 lymphoma CTCL 61 AVASTIN 61 NASDAQ OSIR 61 Luveniq 61 neratinib 61 BENLYSTA ® 61 Temodar ® 61 Fludara ® 61 Response Genetics Inc. 61 Nasdaq RGDX 61 Aztreonam lysine 61 Nasdaq IMGN 61 Cimzia TM 61 anticancer compound 61 CRMD# 61 AMEX REX 61 Albuferon TM 61 ribonucleotide reductase clinically validated 61 Daniel Junius 61 Provectus Pharmaceuticals specializes 61 commercialize deforolimus 61 VitiGam TM 61 investigational therapies 61 receptor tyrosine kinase inhibitor 61 Cethrin 61 Onrigin 61 Phase IIb clinical trials 61 RANK Ligand inhibitor 61 Levoleucovorin 61 oral picoplatin 61 infectious diseases autoimmune 61 RhuDex ® 61 Aradigm Corporation 61 HuMax EGFr 61 ASONEP TM 61 vapreotide acetate 61 FDA Accepts 61 Liprotamase 61 NasdaqGM SPPI 61 Archexin 61 Onalta ™ 61 YONDELIS 61 lintuzumab SGN 61 Sphingomab TM 61 Alocrest 61 Abiraterone acetate 61 virus HCV protease inhibitor 61 Trobalt 61 Proxinium 61 lexidronam injection 61 Arno Therapeutics 61 GATTEX ® 61 Application MAA 61 GTC recombinant form 61 OMRIX Biopharmaceuticals Inc. 61 Neuromodulation System 61 KRYSTEXXA TM pegloticase 61 Bellicum 61 IoGen 61 LEVADEX ™ 61 Development OOPD 61 XL# XL# 61 Sylvie Gregoire President 61 Onalta 61 antibody MT# 61 Gamunex C 61 Hepatocellular Carcinoma HCC 61 Ceflatonin R 61 ACTEMRA TM 61 Emezine 61 IAP inhibitors 61 vitreoretinal disorders 61 Nasdaq VNDA 61 Nipent R 61 Reports Preclinical Data 61 diarrhea predominant irritable 61 infectious diseases autoimmune diseases 61 Orphan Status 61 NYSE Amex PTN 61 Vascular Disrupting Agent 61 Hana Biosciences 61 Submits NDA 61 palifermin 61 DIFICID ™ 61 BrachySil TM 60 refractory metastatic 60 Pirfenidone 60 mifamurtide L MTP PE 60 Receives Orphan Drug 60 HepeX B 60 Expression Genetics 60 ONCASPAR 60 SUTENT ® 60 novel oral anticoagulant 60 Phase Ib study 60 R Saizen R 60 drug conjugate 60 website www.celsion.com 60 #I TM# 60 rasagiline tablets 60 BLA filing 60 CD# CEA 60 recurrent NSCLC 60 MuGard TM 60 Panzem NCD 60 supplemental biologics 60 dermatology therapies 60 DCVax R 60 refractory indolent non 60 dasatinib Sprycel 60 Tezampanel 60 Cardium Therapeutics TM 60 candidate deforolimus 60 topically applied SEPA 60 Orphan Drug Designation 60 multi kinase inhibitor 60 Familial Adenomatous Polyposis FAP 60 Xeloda ® 60 TSX VIR 60 Prestara TM 60 systemic RNAi therapeutic 60 Trofex 60 OTCBB IMUC 60 LEUKINE 60 ALN TTR 60 Lenocta TM 60 Protalex Inc. 60 INSPIRE Trial Phase III 60 Bezielle 60 Granulocyte Colony Stimulating Factor 60 bortezomib Velcade R 60 doxorubicin Transdrug R 60 recurrent metastatic ovarian cancer 60 omacetaxine mepesuccinate 60 CTAP# Capsules 60 JAK inhibitor 60 JZP 60 Simulect 60 Xyfid TM 60 Xanafide 60 TNF Tumor Necrosis Factor 60 cutaneous T cell 60 REGENERX BIOPHARMACEUTICALS INC. 60 OMNARIS HFA 60 Angiocept 60 R lenalidomide 60 candidate REP# 60 Prodarsan R 60 Inc. AMEX YMI 60 triggers apoptosis programmed 60 Presents Preclinical Data 60 CB2 selective receptor agonist 60 sapacitabine CYC# 60 OTC BB PVCT 60 PI3K/Akt pathway inhibitor 60 DAVANAT 60 VEGFR2 inhibitor 60 CIMZIA r 60 relapsed refractory multiple myeloma 60 JOULFERON 60 Campath ® 60 Vidaza azacitidine 60 Zarnestra 60 oral nucleoside analogue 60 Cerimon Pharmaceuticals Inc. 60 Phase 2b Clinical Trial 60 phase IIa clinical 60 OTCBB HXBM developer 60 NASDAQ CXSP announced 60 Talabostat 60 diagnostic radiopharmaceutical 60 CancerVax Corporation 60 thalidomide Thalomid 60 EnzymeRx 60 Loramyc 60 target Galectin receptors 60 immatics 60 Chemokine Therapeutics 60 IRX 2 60 Metastatic Melanoma 60 Orphan Drug status 60 Removab 60 isoform selective 60 Urocidin TM 60 accumulate preferentially 60 Therapeutic Competitors Companies 60 MelaFind R 60 AVXL 60 investigational antibiotic 60 COLAZAL R 60 VIVITROL ® 60 OROS R Hydromorphone 60 Marketing Authorisation Application 60 RhuDex TM 60 HGS ETR1 mapatumumab 60 LBH# 60 OTCQB ABPI 60 Zavesca r 60 Omacetaxine 60 Nasdaq HALO biopharmaceutical 60 TSX VENTURE GAP 60 Cloretazine ® 60 Immunotherapeutic 60 investigational humanized monoclonal antibody 60 Orphan Drug Status 60 Allovectin 7 R 60 Inc. NASDAQ BPAX 60 M2 subunit 60 TBC# 60 Phase Ib IIa 60 Accentia Biopharmaceuticals 60 Plicera 60 Enzyme Replacement Therapy 60 theranostic 60 Ixabepilone 60 Canvaxin 60 induced macular edema 60 Anidulafungin 60 Friedreich Ataxia FRDA 60 immuno inflammatory diseases 60 Ecallantide 60 alfa 2a 60 Inc. PINKSHEETS MEDS 60 StemEx R 60 Kamada AAT 60 MKC# MKC# PP 60 mitogen activated ERK kinase 60 novel immunotherapies 60 TELINTRA R 60 treat chronic sinusitis 60 Initiates Clinical 60 GATTEX TM 60 Receive Milestone Payment 60 Tesmilifene 60 Neurodex 60 Civacir 60 highly purified pasteurized 60 Investigational Treatment 60 RhuDex R 60 EOquin 60 PEG SN# 60 faropenem 60 Orapred ODT 60 Rescula 60 LymphoStat B belimumab 60 Intravenous Human 60 SIR Spheres 60 coronary stent merged 60 label Lipofen R 60 BAY #-# 60 SYCREST 60 OTCQX QRXPY 60 Generx ™ 60 Ganite R 60 targeting CD# 60 OTCBB INSV 60 Cannabinor 60 Meritage Pharma 60 Æterna Zentaris Inc. 60 GTC NASDAQ GTCB 60 HepeX B TM 60 DURECT proprietary 60 Arzerra ofatumumab 60 TRACON Pharmaceuticals 60 ILUVIEN ® 60 sargramostim 60 MCSP respectively 60 YM AIM YMBA 60 topical gel formulation 60 Zelrix 60 Orphan Drug designation 60 Curaxin CBLC# 60 Preotact 60 NYSE AMEX PLX 60 NPC 1C 60 molecular imaging radiopharmaceuticals 60 LEVADEX TM 60 Zenvia TM 60 Ambrisentan 60 PRNewswire FirstCall YM BioSciences 60 Onco TCS 60 Golimumab 60 Monoclonal antibody 60 Ustekinumab 60 eprodisate KIACTA TM 60 tizanidine hydrochloride short 60 Evoltra 60 Velcade bortezomib 60 HQK 60 L BLP# 60 Excellagen 60 regenerative medicine therapies 60 NDA Submission 60 Oxytrex TM 60 Sym# 60 NasdaqGM NTEC today 60 HGS ETR2 60 novel immunotherapeutic 60 Ohr Pharmaceutical Inc. 60 catheter occlusion 60 humanized anti 60 Sanvar R 60 Patient Enrollment 60 human IgG1 monoclonal 60 OvaRex 60 diagnostic molecular imaging 60 Nasdaq INGN 60 OTCBB NRGX 60 OTCBB NVLT biopharmaceutical 60 proteasome inhibitor 60 liposomal formulation 60 Davanat 59 NASDAQ OPXA 59 BioNumerik 59 SinuNase 59 MEK Inhibitor 59 VALSTAR 59 somatostatin analogue 59 OMP #R# 59 PDE4 inhibitor 59 Zalypsis 59 orphan medicinal product 59 CDK cyclin dependent 59 telomerase therapeutic 59 Silodosin 59 alpha folate receptor 59 LHRH antagonist 59 talactoferrin 59 generation PNP inhibitor 59 TRACON Pharmaceuticals Inc. 59 Initiates Clinical Trial 59 MAb therapy 59 rxRNA 59 chimeric monoclonal antibody 59 forodesine hydrochloride 59 Targretin capsules 59 cellular immunotherapy 59 ZARS Pharma 59 evaluating satraplatin 59 pain palliation 59 Phase IIb Trial 59 neovascular diseases 59 Nasdaq SPPI 59 Ketotransdel 59 Inc. Nasdaq VVUS 59 selective androgen receptor modulator 59 Solzira TM 59 Achieves Primary Endpoint 59 Nasdaq ENZN 59 hormone LHRH antagonist 59 advanced carcinoid 59 vidofludimus 59 Inhaled AAT 59 DEB# 59 therapeutic monoclonal antibody 59 MVA HPV IL2 59 TELCYTA 59 Nasdaq TGEN 59 histamine dihydrochloride 59 non porcine pancreatic 59 Inhalation Solution 59 markets Gelclair R 59 NEBIDO R 59 Tumour Vascular Disrupting Agent 59 refractory cutaneous T 59 Nexavar sorafenib 59 Vascugel 59 Solazed ™ 59 Gliadel Wafer 59 EP #R 59 Amrubicin 59 Safinamide 59 ANTEGREN 59 investigational monoclonal antibody 59 AMEX ISV 59 THR beta agonist 59 docetaxel Taxotere R 59 novel VDA molecule 59 Serostim ® 59 glufosfamide 59 acute peripheral arterial 59 product platforms AZX# 59 Plenaxis TM 59 UPLYSO 59 Cinryze ™ 59 memantine HCl 59 Ketotransdel TM 59 humanized monoclonal antibody 59 Submits Response 59 Combination REOLYSIN R 59 Nasdaq IDRA 59 Esbriet pirfenidone 59 REOLYSIN ® 59 oxypurinol 59 apoptosis proteins 59 Besivance 59 selective A2A adenosine receptor 59 including eniluracil ADH 59 triciribine phosphate monohydrate 59 Elotuzumab 59 initiated Phase Ib 59 selective angiogenic kinase inhibitor 59 naronapride 59 #D#C# 59 recurrent metastatic 59 aerosolized AAT 59 tubulin inhibitor 59 Pazopanib 59 PrevOnco ™ 59 Bazedoxifene 59 Orathecin 59 non splenectomized 59 Panzem 59 registrational trial 59 TSX ONY 59 By JAMAAL ABDUL 59 human C1 inhibitor 59 Phase 2b Trial 59 www.ucb group.com 59 metastatic hormone refractory 59 Severe Sepsis 59 SNT-MC#/idebenone 59 Pertuzumab 59 immunotherapy treatments 59 Onalta TM 59 Pralatrexate 59 omega interferon 59 RSR# 59 SPL# Gel vaginal microbicide 59 Fodosine 59 Ceflatonin ® 59 Solazed TM 59 Evoltra TM 59 novel histone deacetylase 59 hyaluronidase enzyme 59 HepaGam B 59 eltrombopag 59 investigational antiplatelet agent 59 manufactures minimally invasive 59 Pivotal Clinical Trial 59 refractory acute myeloid 59 TLR9 agonist 59 BUPHENYL R 59 Solazed 59 JAK1 59 vemurafenib 59 IR BioSciences Holdings 59 NASH Huntington 59 relapsed multiple myeloma 59 eTag assays 59 Repligen Corporation 59 Loramyc R 59 phase IIb study 59 Specifid 59 Urigen Pharmaceuticals Inc. 59 Cynapsus Therapeutics Inc. 59 OTCBB PVCT 59 ISTODAX ® 59 Ventrus 59 Vion Pharmaceuticals 59 Genaera Corporation 59 Squalamine 59 Belimumab 59 lucinactant 59 Anturol TM 59 autoimmune indications 59 Inc. OTCBB IRBS 59 immunologic diseases 59 Aplidin 59 Hedgehog Pathway Inhibitor 59 Metabasis Therapeutics 59 Liposomal 59 GVAX R 59 Fortical R 59 lorvotuzumab mertansine 59 OTCBB TDLP 59 please visit http:/www.vandapharma.com 59 pentadentate logo R 59 Martin Nicklasson CEO 59 Biologic License Application BLA 59 Zemiva TM 59 OTCBB PYTO 59 Tesetaxel 59 personalized immunotherapy 59 CR# vcMMAE 59 acyclovir Lauriad ® 59 XTENT 59 ocular formulation 59 trastuzumab Herceptin R 59 Successfully Completes Phase 59 romidepsin 59 gastrointestinal disorders characterized 59 ProEthic Pharmaceuticals 59 cetuximab Erbitux 59 POSIDUR TM ELADUR TM 59 vaccines oncolytic virus 59 Genasense ® oblimersen 59 investigational pan BCR 59 tezampanel NGX# 59 TKB# 59 Medistem Laboratories 59 Cloretazine R VNP#M 59 NASDAQ ISPH announced 59 Corlux 59 pan histone deacetylase 59 motexafin gadolinium Injection 59 Velac 59 BEMA Granisetron 59 please visit www.medicinova.com 59 orally administered inhibitor 59 Memryte 59 Argatroban 59 Nasdaq ACOR 59 ABL inhibitor 59 TM pralatrexate injection 59 HuCAL antibodies 59 imaging radiopharmaceuticals 59 refractory APL 59 IV Busulfex 59 assessing T DM1 59 EGRIFTA TM 59 Tramiprosate ALZHEMED TM 59 sunitinib malate 59 relapsing multiple sclerosis 59 ThermoDox ® 59 orphan designation 59 RECOTHROM ® 58 Zirgan 58 FS Antihemophilic Factor Recombinant 58 OTCBB DORB 58 PDE# inhibitors 58 reslizumab 58 BiTE R 58 Sphingomab 58 Onyx Pharmaceuticals Announces 58 Telavancin 58 Marqibo 58 http:/www.cytrx.com 58 Torisel temsirolimus 58 Junovan TM 58 chronic idiopathic thrombocytopenic purpura 58 Tibotec Therapeutics division 58 docetaxel Taxotere ® 58 romidepsin novel 58 OTCBB OHRP 58 hereditary emphysema 58 Lubiprostone 58 Rapinyl 58 Supplemental Biologics License Application 58 pharmacological chaperone 58 Syndax Pharmaceuticals Inc. 58 NasdaqGM SPPI commercial 58 follicular Non Hodgkin 58 Aerie Pharmaceuticals 58 Intravenous CP 58 subependymal giant cell 58 NYSE Amex PBTH 58 ALN HTT 58 Catalyst Biosciences 58 immunological diseases 58 pralatrexate 58 ThermoDox ® clinical 58 Octreolin 58 beta 1a 58 RAV# 58 Severe VOD 58 intranasal formulation 58 trastuzumab DM1 58 Brussels THR 58 Alton Boynton 58 HuMax CD4 58 HepaSphere 58 MKC# MT 58 SonoLysis 58 CORLUX CORT # 58 SomatoKine 58 Triapine 58 G#DT 58 ENTB 58 incyclinide 58 EDEMA3 58 recombinant thrombin 58 CIP TRAMADOL ER 58 eniluracil 58 Nasdaq ENMD 58 VISICOL R 58 ganetespib 58 oral ghrelin agonist 58 OTCBB VCRT 58 Cardio Vascu Grow 58 Nasdaq MNKD 58 ImmuneRegen BioSciences Inc. 58 mifamurtide 58 investigational oral hepatitis C 58 Oracea ® 58 Alzhemed TM 58 Indaflex TM 58 Alvine Pharmaceuticals 58 Systemic lupus erythematosus SLE 58 sodium Injection 58 ASX PGL 58 ANYARA 58 ALN HPN 58 Elagolix 58 ® bortezomib 58 MyVax personalized immunotherapy 58 SPRYCEL ® 58 Uvidem 58 AzaSite Plus 58 OTCBB IMNR 58 DexaSite 58 OncoGel 58 Clevudine 58 erlotinib Tarceva ® 58 telomerase inhibitor drug 58 Avila Therapeutics 58 dermatology biopharmaceutical company 58 SYN# 58 therapeutic monoclonal antibodies 58 bevacizumab Avastin ® 58 OvaRex ® MAb 58 Inc. Nasdaq INFI 58 systemic immunosuppressive drugs 58 Taro Receives 58 ChemGenex Pharmaceuticals Limited 58 Dupuytren Contracture 58 Dalbavancin 58 LE DT 58 Guanilib 58 taxane derivative 58 Quinamed 58 Epiphany Biosciences 58 Complete Response 58 Clavis Pharma 58 oral salmon calcitonin 58 Neil K. Warma 58 Æterna Zentaris 58 Aptivus ® 58 Amplimexon 58 radiolabeled TM# 58 Spiro Rombotis President 58 Pradefovir 58 Nimotuzumab 58 Sodium oxybate 58 trial evaluating PRX# 58 Retacrit 58 Exelixis compounds 58 peripherally acting 58 Junovan 58 Transave 58 OncoVEX 58 evaluating tivozanib 58 Kosan Biosciences Incorporated 58 Nasdaq XTLB 58 Kuvan R 58 Regeneron Pharma 58 Cetuximab Erbitux 58 Virulizin R 58 Metabasis Therapeutics Inc. 58 ADP receptor antagonist 58 Ganite 58 adenosine A2A 58 CDP# 58 DepoDur 58 product Fentanyl TAIFUN 58 metastatic castration resistant 58 Tovaxin TM 58 LSE ASM 58 Vicor anticipates 58 inhaled liposomal ciprofloxacin 58 Nasdaq ACEL 58 Nasdaq SNSS 58 NP2 Enkephalin 58 Telatinib 58 Catena ® 58 IIa trial 58 NASDAQ IMCL global 58 Phase IIb III 58 Adrian Hobden Ph.D. 58 HepaLife Technologies Inc. 58 sapropterin dihydrochloride 58 Sumavel DosePro 58 mesylate tablets approved 58 pan HDAC inhibitor 58 Gleevec resistant 58 Ridaforolimus 58 TheraCIM 58 Biomerix Corporation 58 Teysuno 58 phase III isavuconazole 58 Bayer Nexavar 58 Diabetic Macular Edema DME 58 cetrorelix pamoate 58 Aloxi R 58 NASDAQ SNTA 58 Gel repository corticotropin injection 58 CHMP recommendation 58 Phase #/#a trial 58 Orphan Drug designations 58 Bavituximab 58 Maribavir 58 Albugon 58 TSX VENTURE COT 58 individualized cellular immunotherapy 58 ELAPRASE 58 Increlex TM 58 2 methoxyestradiol 58 Nasdaq PPHM 58 Sopherion 58 investigational pharmacologically unique 58 zanolimumab 58 Therapy Evaluation 58 Inc. Nasdaq AVRX 58 5 lipoxygenase inhibitor 58 PRNewswire FirstCall OncoGenex Pharmaceuticals 58 Tamibarotene 58 5 HT4 58 Ph.D. Targacept 58 Yondelis ® 58 Phase III Clinical Trial 58 Durata Therapeutics 58 Azedra TM 58 Azixa 58 HuMax 58 ZFP Therapeutic